Viewing Study NCT04792567


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-25 @ 10:55 PM
Study NCT ID: NCT04792567
Status: COMPLETED
Last Update Posted: 2024-06-20
First Post: 2021-03-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)
Sponsor: Novartis Pharmaceuticals
Organization: